LINC01909

Across TCGA pan-cancer cohorts, LINC01909 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC01909’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC01909 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01909 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

STAD, BLCA, and KICH are the cancer types where LINC01909 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01909 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.579	<.001	9	view →
BLCA	Female	All	+0.356	.001	7	view →
KICH	All	All	−0.339	<.001	7	view →
THCA	All	All	−0.117	.001	6	view →
KIRP	All	II,III,IV	−0.268	.024	4	view →
BRCA	All	All	+0.247	<.001	4	view →
CHOL	All	II,III,IV	−1.544	.027	2	view →
UCEC	All	All	+0.352	.036	2	view →
LUAD	All	III,IV	−0.319	.012	2	view →
COAD	All	All	−0.198	.018	2	view →
KIRC	Male	All	+0.162	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC01909–STAD

Open the STAD breakdown →